Christa D. Payne - Publications

Affiliations: 
Emory University, Atlanta, GA 
Area:
Behavioral Neuroscience

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Wang A, Payne C, Moss S, Jones WR, Bachevalier J. Early developmental changes in visual social engagement in infant rhesus monkeys. Developmental Cognitive Neuroscience. 43: 100778. PMID 32510341 DOI: 10.1016/j.dcn.2020.100778  0.56
2019 Wickremsinhe ER, Hynes SM, Payne CD, Guo Y, Cassidy KC. Disposition of [C]LY2606368 following intravenous administration in patients with advanced and/or metastatic solid tumours. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-12. PMID 31847673 DOI: 10.1080/00498254.2019.1702736  0.01
2019 Payne C, Bachevalier J. Early amygdala damage alters the way rhesus macaques process species-specific audio-visual vocalizations. Behavioral Neuroscience. 133: 1-17. PMID 30688484 DOI: 10.1037/bne0000285  0.56
2017 Posada MM, Cannady EA, Payne CD, Zhang X, Bacon JA, Pak YA, Higgins JW, Shahri N, Hall SD, Hillgren KM. Prediction of Transporter-Mediated Drug-Drug Interactions for Baricitinib. Clinical and Translational Science. PMID 28749581 DOI: 10.1111/Cts.12486  0.01
2016 Raper J, Wilson M, Sanchez M, Payne C, Bachevalier J. Increased anxiety-like behaviors, but blunted cortisol stress response after neonatal hippocampal lesions in monkeys. Psychoneuroendocrinology. 76: 57-66. PMID 27888771 DOI: 10.1016/J.Psyneuen.2016.11.018  0.56
2015 Jakubowski JA, Zhou C, Winters KJ, Lachno DR, Howard J, Payne CD, Mant T, Jurcevic S, Frelinger AL. The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell disease. Platelets. 26: 474-9. PMID 25140584 DOI: 10.3109/09537104.2014.940887  0.01
2014 Meng Y, Payne C, Li L, Hu X, Zhang X, Bachevalier J. Alterations of hippocampal projections in adult macaques with neonatal hippocampal lesions: a Diffusion Tensor Imaging study. Neuroimage. 102: 828-37. PMID 25204865 DOI: 10.1016/J.Neuroimage.2014.08.059  0.56
2014 Payne CD, Deeg MA, Chan M, Tan LH, LaBell ES, Shen T, DeBrota DJ. Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects. British Journal of Clinical Pharmacology. 78: 1334-42. PMID 25039273 DOI: 10.1111/bcp.12470  0.01
2014 Jakubowski JA, Zhou C, Jurcevic S, Winters KJ, Lachno DR, Frelinger AL, Gupta N, Howard J, Payne CD, Mant TG. A phase 1 study of prasugrel in patients with sickle cell disease: effects on biomarkers of platelet activation and coagulation. Thrombosis Research. 133: 190-5. PMID 24368019 DOI: 10.1016/j.thromres.2013.12.008  0.01
2013 Hoppe CJ, Hassler CS, Payne CD, Tortell PD, Rost B, Trimborn S. Iron limitation modulates ocean acidification effects on southern ocean phytoplankton communities. Plos One. 8: e79890. PMID 24278207 DOI: 10.1371/journal.pone.0079890  0.01
2013 Payne C, Bachevalier J. Crossmodal integration of conspecific vocalizations in rhesus macaques. Plos One. 8: e81825. PMID 24236218 DOI: 10.1371/journal.pone.0081825  0.56
2013 Jakubowski JA, Zhou C, Small DS, Winters KJ, Lachno DR, Frelinger AL, Howard J, Mant TG, Jurcevic S, Payne CD. A phase 1 study of prasugrel in patients with sickle cell disease: pharmacokinetics and effects on ex vivo platelet reactivity. British Journal of Clinical Pharmacology. 75: 1433-44. PMID 23171128 DOI: 10.1111/bcp.12042  0.01
2012 Ewing-Cobbs L, Prasad MR, Swank P, Kramer L, Mendez D, Treble A, Payne C, Bachevalier J. Social communication in young children with traumatic brain injury: relations with corpus callosum morphometry. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 30: 247-54. PMID 21807088 DOI: 10.1016/j.ijdevneu.2011.07.004  0.56
2011 Jakubowski JA, Li YG, Payne CD, Small DS, Winters KJ. Absence of "rebound" platelet hyperreactivity following cessation of prasugrel. Thrombosis and Haemostasis. 106: 174-6. PMID 21670844 DOI: 10.1160/TH10-11-0764  0.01
2011 Small DS, Li YG, Ernest CS, April JH, Farid NA, Payne CD, Winters KJ, Rohatagi S, Ni L. Integrated analysis of pharmacokinetic data across multiple clinical pharmacology studies of prasugrel, a new thienopyridine antiplatelet agent. Journal of Clinical Pharmacology. 51: 321-32. PMID 20410452 DOI: 10.1177/0091270010367429  0.01
2010 Small DS, Farid NA, Payne CD, Konkoy CS, Jakubowski JA, Winters KJ, Salazar DE. Effect of intrinsic and extrinsic factors on the clinical pharmacokinetics and pharmacodynamics of prasugrel. Clinical Pharmacokinetics. 49: 777-98. PMID 21053990 DOI: 10.2165/11537820-000000000-00000  0.01
2010 Jakubowski JA, Li YG, Small DS, Payne CD, Tomlin ME, Luo J, Winters KJ. A comparison of the VerifyNow P2Y12 point-of-care device and light transmission aggregometry to monitor platelet function with prasugrel and clopidogrel: an integrated analysis. Journal of Cardiovascular Pharmacology. 56: 29-37. PMID 20386460 DOI: 10.1097/FJC.0b013e3181dd0ec2  0.01
2010 Small DS, Payne CD, Kothare P, Yuen E, Natanegara F, Teng Loh M, Jakubowski JA, Richard Lachno D, Li YG, Winters KJ, Farid NA, Ni L, Salazar DE, Tomlin M, Kelly R. Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy Chinese and white volunteers: an open-label trial. Clinical Therapeutics. 32: 365-79. PMID 20206794 DOI: 10.1016/j.clinthera.2010.02.015  0.01
2010 Small DS, Kothare P, Yuen E, Lachno DR, Li YG, Winters KJ, Farid NA, Ni L, Jakubowski JA, Salazar DE, Thieu VT, Payne CD. The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects. European Journal of Clinical Pharmacology. 66: 127-35. PMID 19888568 DOI: 10.1007/s00228-009-0737-1  0.01
2009 Small DS, Wrishko RE, Ernest CS, Ni L, Winters KJ, Farid NA, Li YG, Brandt JT, Salazar DE, Borel AG, Kles KA, Payne CD. Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease. Journal of Clinical Pharmacy and Therapeutics. 34: 585-94. PMID 19744014 DOI: 10.1111/j.1365-2710.2009.01068.x  0.01
2009 Small DS, Farid NA, Li YG, Ernest CS, Winters KJ, Salazar DE, Payne CD. Pharmacokinetics and pharmacodynamics of prasugrel in subjects with moderate liver disease. Journal of Clinical Pharmacy and Therapeutics. 34: 575-83. PMID 19744013 DOI: 10.1111/j.1365-2710.2009.01067.x  0.01
2009 Small DS, Wrishko RE, Ernest CS, Ni L, Winters KJ, Farid NA, Li YG, Salazar DE, Payne CD. Effect of age on the pharmacokinetics and pharmacodynamics of prasugrel during multiple dosing: an open-label, single-sequence, clinical trial. Drugs & Aging. 26: 781-90. PMID 19728751 DOI: 10.2165/11315780-000000000-00000  0.01
2009 Li YG, Ni L, Brandt JT, Small DS, Payne CD, Ernest CS, Rohatagi S, Farid NA, Jakubowski JA, Winters KJ. Inhibition of platelet aggregation with prasugrel and clopidogrel: an integrated analysis in 846 subjects. Platelets. 20: 316-27. PMID 19637095 DOI: 10.1080/09537100903046317  0.01
2009 Farid NA, Jakubowski JA, Payne CD, Li YG, Jin Y, Ernest II CS, Winters KJ, Brandt JT, Salazar DE, Small DS. Effect of rifampin on the pharmacokinetics and pharmacodynamics of prasugrel in healthy male subjects. Current Medical Research and Opinion. 25: 1821-9. PMID 19530977 DOI: 10.1185/03007990903018360  0.01
2008 Farid NA, Small DS, Payne CD, Jakubowski JA, Brandt JT, Li YG, Ernest CS, Salazar DE, Konkoy CS, Winters KJ. Effect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjects. Pharmacotherapy. 28: 1483-94. PMID 19025429 DOI: 10.1592/phco.28.12.1483  0.01
2008 Small DS, Farid NA, Li YG, Ernest CS, Payne CD, Salazar DE, Winters KJ. Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel. Current Medical Research and Opinion. 24: 2251-7. PMID 18786302 DOI: 10.1185/03007990802205985  0.01
2008 Payne CD, Li YG, Brandt JT, Jakubowski JA, Small DS, Farid NA, Salazar DE, Winters KJ. Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects. Platelets. 19: 275-81. PMID 18569863 DOI: 10.1080/09537100801891640  0.01
2008 Small DS, Farid NA, Payne CD, Weerakkody GJ, Li YG, Brandt JT, Salazar DE, Winters KJ. Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel. Journal of Clinical Pharmacology. 48: 475-84. PMID 18303127 DOI: 10.1177/0091270008315310  0.01
2008 Jakubowski JA, Payne CD, Li YG, Brandt JT, Small DS, Farid NA, Salazar DE, Winters KJ. The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration. Thrombosis and Haemostasis. 99: 409-15. PMID 18278193 DOI: 10.1160/TH07-09-0575  0.01
2008 Jakubowski JA, Payne CD, Li YG, Farid NA, Brandt JT, Small DS, Salazar DE, Winters KJ. A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry. Thrombosis and Haemostasis. 99: 215-22. PMID 18217157 DOI: 10.1160/TH07-09-0555  0.01
2008 Farid NA, Payne CD, Ernest CS, Li YG, Winters KJ, Salazar DE, Small DS. Prasugrel, a new thienopyridine antiplatelet drug, weakly inhibits cytochrome P450 2B6 in humans. Journal of Clinical Pharmacology. 48: 53-9. PMID 18094219 DOI: 10.1177/0091270007309709  0.01
2007 Payne CD, Li YG, Small DS, Ernest CS, Farid NA, Jakubowski JA, Brandt JT, Salazar DE, Winters KJ. Increased active metabolite formation explains the greater platelet inhibition with prasugrel compared to high-dose clopidogrel. Journal of Cardiovascular Pharmacology. 50: 555-62. PMID 18030066 DOI: 10.1097/FJC.0b013e3181492209  0.01
2007 Brandt JT, Close SL, Iturria SJ, Payne CD, Farid NA, Ernest CS, Lachno DR, Salazar D, Winters KJ. Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel. Journal of Thrombosis and Haemostasis : Jth. 5: 2429-36. PMID 17900275 DOI: 10.1111/j.1538-7836.2007.02775.x  0.01
2007 Weerakkody GJ, Jakubowski JA, Brandt JT, Payne CD, Naganuma H, Winters KJ. Greater inhibition of platelet aggregation and reduced response variability with prasugrel versus clopidogrel: an integrated analysis. Journal of Cardiovascular Pharmacology and Therapeutics. 12: 205-12. PMID 17875947 DOI: 10.1177/1074248407304731  0.01
2007 Weerakkody GJ, Brandt JT, Payne CD, Jakubowski JA, Naganuma H, Winters KJ. Clopidogrel poor responders: an objective definition based on Bayesian classification. Platelets. 18: 428-35. PMID 17763152 DOI: 10.1080/09537100701206790  0.01
2007 Weerakkody GJ, Jakubowski JA, Brandt JT, Farid NA, Payne CD, Zhu J, Warner MR, Naganuma H, Winters KJ. Comparison of speed of onset of platelet inhibition after loading doses of clopidogrel versus prasugrel in healthy volunteers and correlation with responder status. The American Journal of Cardiology. 100: 331-6. PMID 17631093 DOI: 10.1016/j.amjcard.2007.02.103  0.01
2007 Jakubowski JA, Payne CD, Weerakkody GJ, Brandt JT, Farid NA, Li YG, Naganuma H, Lachno DR, Winters KJ. Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects. Journal of Cardiovascular Pharmacology. 49: 167-73. PMID 17414229 DOI: 10.1097/FJC.0b013e318031301b  0.01
2007 Farid NA, Payne CD, Small DS, Winters KJ, Ernest CS, Brandt JT, Darstein C, Jakubowski JA, Salazar DE. Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently. Clinical Pharmacology and Therapeutics. 81: 735-41. PMID 17361128 DOI: 10.1038/sj.clpt.6100139  0.01
2007 Brandt JT, Payne CD, Wiviott SD, Weerakkody G, Farid NA, Small DS, Jakubowski JA, Naganuma H, Winters KJ. A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation. American Heart Journal. 153: 66.e9-16. PMID 17174640 DOI: 10.1016/j.ahj.2006.10.010  0.01
2007 Forgue ST, Phillips DL, Bedding AW, Payne CD, Jewell H, Patterson BE, Wrishko RE, Mitchell MI. Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics. British Journal of Clinical Pharmacology. 63: 24-35. PMID 16869816 DOI: 10.1111/j.1365-2125.2006.02726.x  0.01
2006 Jakubowski JA, Payne CD, Brandt JT, Weerakkody GJ, Farid NA, Small DS, Naganuma H, Li GY, Winters KJ. The platelet inhibitory effects and pharmacokinetics of prasugrel after administration of loading and maintenance doses in healthy subjects. Journal of Cardiovascular Pharmacology. 47: 377-84. PMID 16633079 DOI: 10.1097/01.fjc.0000210069.47205.c0  0.01
2006 Jernberg T, Payne CD, Winters KJ, Darstein C, Brandt JT, Jakubowski JA, Naganuma H, Siegbahn A, Wallentin L. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease. European Heart Journal. 27: 1166-73. PMID 16621870 DOI: 10.1093/eurheartj/ehi877  0.01
2006 Forgue ST, Patterson BE, Bedding AW, Payne CD, Phillips DL, Wrishko RE, Mitchell MI. Tadalafil pharmacokinetics in healthy subjects. British Journal of Clinical Pharmacology. 61: 280-8. PMID 16487221 DOI: 10.1111/j.1365-2125.2005.02553.x  0.01
2005 Ring BJ, Patterson BE, Mitchell MI, Vandenbranden M, Gillespie J, Bedding AW, Jewell H, Payne CD, Forgue ST, Eckstein J, Wrighton SA, Phillips DL. Effect of tadalafil on cytochrome P450 3A4-mediated clearance: studies in vitro and in vivo. Clinical Pharmacology and Therapeutics. 77: 63-75. PMID 15637532 DOI: 10.1016/j.clpt.2004.09.006  0.01
2004 Pearson DA, Lane DM, Santos CW, Casat CD, Jerger SW, Loveland KA, Faria LP, Mansour R, Henderson JA, Payne CD, Roache JD, Lachar D, Cleveland LA. Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response. Journal of the American Academy of Child and Adolescent Psychiatry. 43: 686-98. PMID 15167085 DOI: 10.1097/01.Chi.0000120024.14101.96  0.56
2004 Pearson DA, Santos CW, Casat CD, Lane DM, Jerger SW, Roache JD, Loveland KA, Lachar D, Faria LP, Payne CD, Cleveland LA. Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 43: 677-85. PMID 15167084 DOI: 10.1097/01.Chi.0000124461.81324.13  0.56
Show low-probability matches.